| Literature DB >> 35350663 |
Ionuţ Mădălin Gridan1, Alecu Aurel Ciorsac2, Adriana Isvoran1.
Abstract
Within this study we have considered 9 triazole fungicides that are approved to be used in European Union for protecting cereals: cyproconazole, epoxiconazole, flutriafol, metconazole, paclobutrazole, tebuconazole, tetraconazole, triadimenol and triticonazole. We have summarized the few available data that support their effects on humans and used various computational tools to obtain a widely view concerning their possible harmful effects on humans. The results of our predictive study reflect that all triazole fungicides considered in this study reveal good oral bioavailability, are envisaged as being able to penetrate the blood brain barrier and to interact with P-glycoprotein and with hepatic cytochromes. The predictions concerning the toxicological endpoints for the investigated triazole fungicides reveal that they. reflect potential of skin sensitization, of blockage of the hERG K+ channels and of endocrine disruption, that they have not mutagenic potential and their carcinogenic potential is not clear. Epoxiconazole and triadimenol are predicted to have the highest potentials of producing numerous harmful effects on humans and their use should be avoided or limited.Entities:
Keywords: carcinogenicity; cardiotoxicity; endocrine disruption; mutagenicity; oral bioavailability
Year: 2019 PMID: 35350663 PMCID: PMC8957235 DOI: 10.5599/admet.668
Source DB: PubMed Journal: ADMET DMPK ISSN: 1848-7718
Figure 1.Structural formulas of triazole fungicides considered in the present study, their common and IUPAC names
Known human health effects of triazole fungicides used for cereals protection
| Triazole fungicide | Skin/eye irritations | Respiratory tract irritant | Carcinogenicity/Mutagenicity | Endocrine disruption potential | Reproductive toxicity | Hepato-toxicity | Neuro-toxicity |
|---|---|---|---|---|---|---|---|
| cyproconazole | Mild eye irritant (TOXNET), skin and eye irritant (PPDB) | Yes (PPDB) | Probable carcinogen | Inhibition of aromatase activity, decrease of estrogens production (PPDB) | No data found. | Possible liver toxicant (PPDB) | No (PPDB) |
| epoxiconazole | No (PPDB) | No (PPDB) | probable carcinogen (PPDB, PubChem, PAN)/ No data found. | inhibition of aromatase activity, decrease of estrogen production (PPDB), suspect to produce endocrine disruption (PAN) | No data found. | Liver toxicant (PPDB) | No (PPDB) |
| flutriafol | NO (PPDB) | Yes (PPDB) | No (PPDB, PAN)/ No data found. | Weak estrogen inhibition (PPDB), suspect to produce endocrine disruption (PAN) | No data found. | Possible liver toxicant (PPDB) | No (PPDB) |
| metconazole | NO (PPDB) | Yes (PPDB) | No (PPDB, PAN)/ No data found. | No data found. | Suspect of damaging fertility or the unborn child. (PubChem) | Possible liver toxicant (PPDB) | No (PPDB) |
| paclobutrazole | Yes (PPDB, PubChem) | No data found. | NO (PPDB)/ | No data found. | Suspect of damaging fertility or the unborn child. (PubChem) | No data found. | No (PPDB) |
| tebuconazole | Eye irritant (PPDB) | No (PPDB) | probable carcinogen (TOXNET, PAN)/ NO (PPDB) | NO (PPDB), suspect to produce endocrine disruption (PAN) | Yes (PPDB, PubChem) | No data found. | No (PPDB) |
| tetraconazole | Eye irritant (TOXNET), no effects (PPDB) | No (ToxNET, PPDB) | probable carcinogen (TOXNET, PPDB, PAN)/ No (PPDB) | No (PPDB) | No data found. | Liver toxicant (PPDB) | No (PPDB) |
| triadimenol | Yes (TOXNET, PPDB) | YES (TOXNET, PPDB) | probable carcinogen (PPDB, PAN)/ No data found. | Yes (TOXNET), estrogenic effect (PPDB), suspect to produce endocrine disruption (PAN) | Yes (PPDB, PubChem) | Liver toxicant (PPDB) | No data found. |
| triticonazole | No (PPDB) | No (PPDB) | probable carcinogen (TOXNET), noncarcinogen (PPDB)/ No data found. | No data found. | No data found. | No data found. | No data found. |
Prediction of the ADMET profiles obtained using the FAFDrugs4 computational tool for the triazole fungicides considered in this study: green boxes correspond to rules that are respected, orange boxes correspond to rules that are partially violated and red grey boxes correspond to rules that are not respected.
|
|
Prediction of the pharmacokinetics profiles of the triazole fungicides using SwissADME computational tool: GI- gastrointestinal absorption, BBB- blood brain barrier permeant, P-gp – P-glycoprotein, CYP – human cytochrome, log Kp - skin penetration coefficient in logarithmic scale.
| Active substance | GI absorption | BBB permeant | P-gp substrate | CYP1A2 | CYP2C19 | CYP2C9 | CYP2D6 | CYP3A4 | log |
|---|---|---|---|---|---|---|---|---|---|
| cyproconazole | High | Yes | No | No | Yes | No | No | No | -6.02 |
| epoxiconazole | High | Yes | Yes | No | Yes | Yes | Yes | No | -5.87 |
| flutriafol | High | Yes | No | No | Yes | No | Yes | No | -6.50 |
| metconazole | High | Yes | No | No | Yes | No | Yes | No | -5.52 |
| paclobutrazole | High | Yes | No | No | Yes | No | No | No | -5.82 |
| tebuconazole | High | Yes | No | Yes | Yes | No | Yes | No | -5.55 |
| triticonazole | High | Yes | Yes | No | Yes | Yes | No | No | -5.87 |
| triadimenol | High | Yes | No | No | Yes | No | No | No | -5.92 |
| tetraconazole | High | Yes | No | Yes | Yes | Yes | No | No | -6.04 |
Prediction of skin sensitization potential of the considered triazole fungicides: LLNA - murine local lymph node assay, DRPA - direct peptide reactivity assay, h-CLAT - human cell line activation test. Green boxes correspond to predictions of non-sensitizer potential, orange boxes to predictions of moderate skin sensitizer potential and red boxes illustrate predictions of skin sensitizer potential. Numbers in parenthesis correspond to the accuracy of every prediction.
|
|
Figure 2.The redicted probability map of the predicted contribution of chemical fragments of cyproconazole to: (A) skin sensitization potential; (B) blockage of the hERG K+ channels. Green color corresponds to atoms illustrating an increase in skin sensitization (A) or towards blockage of hERG (B), pink color corresponds to atoms emphasizing a decrease in skin sensitization (A) or in hERG blockage (B) and gray lines delimit the region of split between the positive and negative contributors toward skin sensitization (A) or hERG blockage (B). More continuous contour lines mean an increased pozitive contribution and more dashed contour lines mean an increased negative contribution of an atom to skin sensitization (A) or hERG blockage (B) respectively.
Predictions concerning the following toxicological endpoints: cardiotoxicity, carcinogenicity and mutagenicity of investigated triazole fungicides.
| Fungicide | h_ERG channel blockage predictions | CarcinoPred-EL predictions for carcinogenicity | Toxtree predictions | |||||
|---|---|---|---|---|---|---|---|---|
| binary model | multiclass model | XGBoost model | RF model | SVM model | genotoxic carcino-genicity | non genotoxic carcino-genicity | Ames muta-genicity | |
| cyproconazole | blocker | Non-Blocker | No | No | No | No | Yes | No |
| epoxiconazole | blocker | Non-Blocker | No | No | No | yes | Yes | No |
| flutriafol | blocker | Non-Blocker | Yes | Yes | Yes | No | No | No |
| metconazole | blocker | Non-Blocker | No | No | No | No | Yes | No |
| paclobutrazole | blocker | Non-Blocker | Yes | No | No | No | Yes | No |
| tebuconazole | blocker | Non-Blocker | No | No | No | No | Yes | No |
| tetraconazole | blocker | Non-Blocker | No | No | No | No | No | No |
| triadimenol | blocker | Non-Blocker | Yes | No | No | No | Yes | No |
| triticonazole | blocker | Non-Blocker | Yes | No | No | No | Yes | No |
Prediction of the endocrine disruption potential of investigated triazole fungicides: red boxes correspond to the high probability of binding, orange boxes correspond to intermediate probability of binding, yellow boxes correspond to moderate probability of binding and green boxes correspond to low probability of binding of triazole fungicides to these receptors.
|
|